Rilzabrutinib, a monoclonal antibody, has demonstrated rapid and durable platelet responses, improved health-related quality of life, and was generally well-tolerated in adults with difficult-to-treat Immune Thrombocytopenia (ITP). The findings, from the phase 3 LUNA 3 study, were presented at the American Society of Hematology Annual Meeting. The study enrolled adults and children aged 10 years … Read more
A surge in traffic hit a server, causing it to become overwhelmed and send an error message to the client. The details of the incident include a client IP address (37.27.54.14) and a request ID number (883504091). This type of issue often occurs when a website or online application experiences an unexpected spike in user … Read more
President-elect Donald Trump has appointed David Sacks, a Silicon Valley insider and former CEO of Yammer, as his AI and cryptocurrency czar. This move is expected to have significant implications for the tech industry, particularly for companies focused on artificial intelligence (AI) and cryptocurrency. Sacks’ appointment, along with Elon Musk’s role in the cabinet, is … Read more
The American Society of Hematology (ASH) conference in San Diego saw several significant advancements in the treatment of rare blood disorders. Sanofi’s new oral medication, rilzabrutinib, achieved improved platelet counts and reduced bleeding episodes in patients with a rare autoimmune disorder that causes the body to attack its own blood-clotting platelets. Novo Nordisk also made … Read more
A Moon Alert has been issued for Monday, December 9, 2024, between 2:30 a.m. and 9 a.m. Chicago time. During this period, it’s recommended to avoid shopping or making big decisions. As the moon transitions from Pisces to Aries, individual horoscopes are as follows: Aries (March 21-April 19): Expect confidence and stronger relationships due to … Read more
A ketogenic diet supplement has shown promise in improving cancer-fighting immune cells, according to new research. The study found that a low-carb diet can increase the effectiveness of CAR T cell therapy, a personalized treatment that reprograms patients’ own immune cells to kill cancer. Researchers at the University of Pennsylvania and Penn Medicine’s Abramson Cancer … Read more
Investors are waiting with bated breath for earnings and CPI data as the year-end market optimism hangs in the balance. Despite global instability and economic uncertainty intensifying worldwide, stocks have been relatively calm with the S&P 500 gaining 1% and the Nasdaq Composite jumping 3.3%. The Dow Jones Industrial Average fell over 0.5%, however. The … Read more
Palantir Technologies’ stock has gained over 300% this year, with the company expected to be added to the Nasdaq-100 index on December 13. While this milestone could lead to a short-term price increase, investors should consider the company’s growth outlook, Wall Street’s opinion, and valuation before making a decision. Palantir’s growth is driven by its … Read more
Marvel Rivals has been out for a few days now, and players are eager to know which heroes will give them an edge in ranked play. A tier list has been created to help players make informed decisions about their team compositions. **Duelist (DPS) Tier List** 1. Scarlet Witch – A monster in Marvel Rivals, … Read more
Pat Gelsinger’s sudden departure from Intel has left the company reeling, with many questioning whether the new CEO can stem the tide of decline that has plagued the chipmaker in recent years. The 63-year-old executive, who had been at the helm since 2021, failed to deliver on his promise to revitalize the company through massive … Read more